p53 has been suggested to inactivate HIF1 and, as a result, inhibit the expression of PDHK, promoting metabolic reprogramming and the antineoplastic effects of Dichloroacetat (DCA) on glioma cells [147]. This evidence concerns the gene TP53 and central nervous system cancer.